FIELD: medicine.
SUBSTANCE: proposed are compositions containing combinations of a compound by the formula (I) and one or more immune checkpoint inhibitors for treatment of cancer. Some implementations relate to methods for treating cancer by co-administration of a compound by the formula (I) and one or more immune checkpoint inhibitors to a subject in need thereof. Some implementations relate to methods for treating cancer by means of co-administration of a compound by the formula (I) and plinabulin to a subject in need thereof.
EFFECT: technical result of the invention is production of compositions applicable in treatment of cancer.
45 cl, 4 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTITUMOR COMBINATION OF CHIDAMIDE AND CELECOXIB | 2019 |
|
RU2811733C1 |
| NOVEL APPROACH TO CANCER TREATMENT USING IMMUNOMODULATION | 2016 |
|
RU2817047C2 |
| IMMUNE RESPONSE PRESERVATION DURING CHEMOTHERAPEUTICAL SHEMES | 2017 |
|
RU2779478C2 |
| IMMUNE-MODIFYING PARTICLES FOR CANCER TREATMENT | 2019 |
|
RU2794261C2 |
| PEPTIDES IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS FOR USE IN TREATING CANCER | 2020 |
|
RU2826955C2 |
| TYPES OF COMBINATION THERAPY FOR TREATING CANCER | 2021 |
|
RU2816314C1 |
| COMPOSITIONS CONTAINING NAPHTHYRIDINE DERIVATIVES AND ALUMINUM-CONTAINING AUXILIARY AGENT, INTENDED FOR USE IN TREATMENT OF SOLID TUMORS | 2018 |
|
RU2787157C2 |
| NEW APPROACH TO TREATING CANCER WITH APPLICATION OF IMMUNOMODULATION | 2016 |
|
RU2711380C2 |
| USE OF THE PLINABULIN IN COMBINATION WITH THE IMMUNE RESPONSE CONTROL POINT INHIBITORS | 2016 |
|
RU2723021C2 |
| SEQUENTIAL CANCER TREATMENT USING 6-THIO-dG, CHECKPOINT INHIBITORS AND RADIATION THERAPY | 2021 |
|
RU2833475C1 |
